These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Indications and results of monoamine treatment in parkinsonian syndromes]. Boudin G; Pépin B; Guillard A; Fabiani JM; Haguenau M Rev Neurol (Paris); 1972 Jul; 127(1):79-97. PubMed ID: 4520464 [No Abstract] [Full Text] [Related]
3. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]. Birkmayer W; Linauer W; Mentasti M; Riederer P Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492 [No Abstract] [Full Text] [Related]
4. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
5. [10 years of L-DOPA therapy of Parkinson's syndrome]. Birkmayer W Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333 [No Abstract] [Full Text] [Related]
6. [Effect of a combined L-Dopa and decarboxylase inhibitor (Ro 4-4602) therapy in parkinsonism patients. Quantitative analysis of bradykinesia using reaction times]. Kaufmann W; Butz P; Wiesendanger M Dtsch Z Nervenheilkd; 1969 Dec; 197(1):85-100. PubMed ID: 5364658 [No Abstract] [Full Text] [Related]
7. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism. Jenkins AC; Schwieger AC Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186 [No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study]. Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149 [No Abstract] [Full Text] [Related]
9. Failures of L-dopa. Paulson GW Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406 [No Abstract] [Full Text] [Related]
10. [Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)]. Gehlen W; Eisenlohr JJ Nervenarzt; 1974 Jan; 45(2):22-9. PubMed ID: 4601993 [No Abstract] [Full Text] [Related]
11. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study]. Tissot R; de Ajuriaguerra J Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226 [No Abstract] [Full Text] [Related]
12. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism. Knutsson E; Mårtensson A; Meyerson BA; Risberg AM Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551 [No Abstract] [Full Text] [Related]
13. Production of involuntary movements by L-dopa in monkeys with tegmental lesions. Battista AF; Goldstein M; Ogawa M Exp Neurol; 1971 Dec; 33(3):566-75. PubMed ID: 5002323 [No Abstract] [Full Text] [Related]
14. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)]. Steinhäusl H Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743 [No Abstract] [Full Text] [Related]
15. [Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor]. Streifler M; Vardi J; Kesten M Harefuah; 1972 Nov; 83(9):362-4. PubMed ID: 4669737 [No Abstract] [Full Text] [Related]
16. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports]. Rosati G; Agnetti V; Mura F; Granieri E Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058 [No Abstract] [Full Text] [Related]
17. [Abnormal movements induced by L-Dopa and dopamine metabolism disorders]. Lhermitte F; Rosa A; Comoy E; Bohuon C Rev Neurol (Paris); 1973 Dec; 129(6):313-24. PubMed ID: 4794176 [No Abstract] [Full Text] [Related]
18. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050 [No Abstract] [Full Text] [Related]
19. [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor]. Siegfried J; Klaiber R; Perret E; Ziegler WH Dtsch Med Wochenschr; 1969 Dec; 94(52):2678-81. PubMed ID: 4903342 [No Abstract] [Full Text] [Related]
20. [Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism]. Presthus J Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2119. PubMed ID: 4773985 [No Abstract] [Full Text] [Related] [Next] [New Search]